<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A5CC1180-2386-42BD-B1A9-14DC84D52ED1"><gtr:id>A5CC1180-2386-42BD-B1A9-14DC84D52ED1</gtr:id><gtr:name>European Centre for Disease Prevention and Control (ECDC)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Epidemiology &amp; Public Health</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A5CC1180-2386-42BD-B1A9-14DC84D52ED1"><gtr:id>A5CC1180-2386-42BD-B1A9-14DC84D52ED1</gtr:id><gtr:name>European Centre for Disease Prevention and Control (ECDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8A54E5C1-EC36-4718-8C34-8B86ADFE4E31"><gtr:id>8A54E5C1-EC36-4718-8C34-8B86ADFE4E31</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>White</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/435BF509-4C81-4659-8E74-9778D7B1416D"><gtr:id>435BF509-4C81-4659-8E74-9778D7B1416D</gtr:id><gtr:firstName>Andy</gtr:firstName><gtr:surname>Winter</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A1A50B2C-729F-48C6-97A9-3B21B66AE81B"><gtr:id>A1A50B2C-729F-48C6-97A9-3B21B66AE81B</gtr:id><gtr:firstName>Patrick</gtr:firstName><gtr:surname>French</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/26741BBA-841E-4B3F-B08D-AFE69842B338"><gtr:id>26741BBA-841E-4B3F-B08D-AFE69842B338</gtr:id><gtr:firstName>Catherine</gtr:firstName><gtr:otherNames>A</gtr:otherNames><gtr:surname>Ison</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F0F87B8E-489E-4CBF-AF9A-A900E90652DD"><gtr:id>F0F87B8E-489E-4CBF-AF9A-A900E90652DD</gtr:id><gtr:firstName>Ann</gtr:firstName><gtr:surname>Sullivan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7A455869-7D58-4444-8A22-8B89EC664C10"><gtr:id>7A455869-7D58-4444-8A22-8B89EC664C10</gtr:id><gtr:firstName>Helen</gtr:firstName><gtr:surname>Ward</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601699"><gtr:id>8B55EE7B-1ECF-4850-BAFC-F519E3CE9E41</gtr:id><gtr:title>LGV-net: a clinical, molecular and epidemiological study of LGV in the UK</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601699</gtr:grantReference><gtr:abstractText>Lymphogranuloma venereum (LGV) is a sexually transmitted infection caused by a type of chlamydia bacteria. Until recently it has been considered a tropical infection that is rarely seen in the UK. Since 2003 there has been a re-emergence of this infection in the UK, Europe, North America and most recently Australia. It is affecting men who have sex with men (MSM). Most of the cases have also had HIV infection. Unlike the common form of Chlamydia, LGV is an invasive disease capable of causing tissue destruction and severe symptoms. Once diagnosed, it is easily treated with a course of antibiotics. However, the symptoms can be similar to other gastrintestinal diseases, and a number of patients have been misdiagnosed resulting in hospitalisation and unnecessary operations. In addition, LGV causes inflammation of the genitals or rectum that will increase the risk of acquiring HIV and of passing it on to partners. 
In the UK in October 2004 the Health Protection Agency (HPA) established a national service to diagnose and monitor LGV. Since then over 400 cases have been diagnosed, more than in any other country. This system provides a broad overview of the outbreak, but is not in enough detail to allow us to understand and control the disease. 
We are asking the MRC to fund a network to carry out more detailed investigations of this outbreak. We will ask patients who have LGV or who have symptoms suggesting LGV, plus their sexual partners, to do a computer-based interview. This will contain questions on their symptoms, other medical problems and their sexual history. This will be linked to a detailed clinical record of their signs, test results and treatment. We will also carry out molecular sub-typing (genetic fingerprinting) of the LGV strains. This will help us to decide whether this is a single outbreak in a large network (a group of people linked by sex) or a series of smaller outbreaks. 
The research network includes the clinics that have seen most cases in England (four in London and one in Brighton) and Scotland (Glasgow). The results of the study will be used to help doctors diagnose and treat LGV. We will also advise patient and community groups about the best way to recognise and prevent LGV.</gtr:abstractText><gtr:technicalSummary>Lymphogranuloma venereum (LGV) is a sexually transmitted infection caused by a type of Chlamydia trachomatis (L1-3). Until recently it has been considered a tropical infection that is rarely seen in the UK. Since 2003 there has been a re-emergence of this infection, with outbreaks reported in the UK, Europe, North America and Australia. The cases have been predominantly in men who have sex with men (MSM), many of whom are also infected with HIV. Unlike the more common forms of C trachomatis (D-K), LGV is an invasive disease capable of causing tissue destruction and severe symptoms. The UK has experienced the largest ongoing outbreak, with 401 cases identified in the past two years since a national diagnostic and surveillance system was established. Routine surveillance has identified the main features of the outbreak, but there are key questions that require more detailed research: what is the natural history of LGV in MSM? Why is there such a high level of co-infection between LGV and HIV? Does the natural history of LGV differ in men with HIV infection, and does LGV alter the course of HIV disease? Are current treatment regimens achieving microbiological and clinical cure? What are the predominant routes of LGV transmission in MSM? What is the nature of the networks in which LGV is being transmitted? Are UK cases part of a linked outbreak based on a large connected network with a single circulating strain of LGV, or are there several distinct strains and networks?
The Department of Infectious Disease Epidemiology at Imperial College will lead a research network including five large UK clinics and the the national reference laboratory at the Health Protection Agency. We will carry out a detailed descriptive prospective study of men with LGV and their sexual contacts, using Computer Assisted Self Interview. We will compare the clinical course of disease in men with and without HIV infection, and subtype LGV to try and identify transmission networks. We will also develop a disease transmission model for LGV using parameters estimated from this research in order to better understand transmission and identify appropriate interventions. 
This research will be used to improve diagnosis, treatment and prevention of LGV in the UK and elsewhere.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>319440</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Centre for Disease Prevention and Control (ECDC)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>ECDC</gtr:description><gtr:id>92317018-DB7E-475E-B0ED-8D1DB4D9D31F</gtr:id><gtr:impact>Presentation at ECDC STIHIV conference in December 2009.</gtr:impact><gtr:outcomeId>5EABC902F81-1</gtr:outcomeId><gtr:partnerContribution>Sharing information and contacts in relation to the LGV outbreak in other parts of Europe.</gtr:partnerContribution><gtr:piContribution>We have shared information and insights from our interim analyses.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre of Infectious Disease Surveillance and Control</gtr:department><gtr:description>HPA</gtr:description><gtr:id>D3169EE1-3587-40A8-A877-7145EB913B70</gtr:id><gtr:impact>Include the publications listed, all of which were done in collaboration with the HPA.</gtr:impact><gtr:outcomeId>A00730D2752-1</gtr:outcomeId><gtr:partnerContribution>They provide backgound information on the epidemic of LGV in the UK as a whole, including surveillance data, testing and diagnostic data.</gtr:partnerContribution><gtr:piContribution>We contribute the the HPA LGV incident group</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation to microbiology STI network and STBRL</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6F3A37C5-A3C2-48C5-AD81-C9FC271FEBF3</gtr:id><gtr:impact>80 people attended, mostly microbiologists who found out more about te importance of LGV and isseus around diagnosis

n/a</gtr:impact><gtr:outcomeId>mefgf2sn4o9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ECDC Annual STI/HIV Surveillance Network Meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2D8D877F-A5D5-44E2-955C-40711A8A7ED9</gtr:id><gtr:impact>Helen Ward presented interim results of the study as part of a workshop on STI in men who have sex with men. This was arranged by ECDC HIV and STI programme and was to an audience of professionals from around Europe who work in surveillance and public health.

Planned discussions of a European collaborative study</gtr:impact><gtr:outcomeId>6B825F0E5B8</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to CHAPS conference of health promotors</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3BCE8978-024C-4B33-BB36-FA73287C2515</gtr:id><gtr:impact>100+ people attended the session on LGV which was well received. 


following this discussions led to production of a revised leaflet for MSM which is being distributed through clinics</gtr:impact><gtr:outcomeId>JoX7PqaJHr8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New leaflet and publicitiy campaign on LGV for MSM</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B1D8B684-277A-4330-BAB1-1E8B4984CDFA</gtr:id><gtr:impact>We worked with professional and patient organisations to inform them of our findings and the resutls informed newspaper articles in the gay press, printed and webmaterial for men at risk

distribution of the leaflet etc</gtr:impact><gtr:outcomeId>CrZrEYyeUWp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>249998</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Research for Patient Benefit Programme</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>PB-PG-0212-27041</gtr:fundingRef><gtr:id>A46CB4B1-4162-4CF4-A3D3-8DA5DA0E1B26</gtr:id><gtr:outcomeId>h4JyvZZqRLe</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>467844</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2014-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>090285/Z/09/Z</gtr:fundingRef><gtr:id>A4CB130B-27AF-419C-9090-326F183533CA</gtr:id><gtr:outcomeId>ERBDy6sw4bz</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>2013 UK National Guideline for the management of lymphogranuloma venereum</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:guidelineTitle>2013 UK National Guideline for the management of lymphogranuloma venereum</gtr:guidelineTitle><gtr:id>0FFA4526-D0DC-4A6D-8725-75054D41DE0F</gtr:id><gtr:impact>Evidence of the prevalence of LGV and the trends in the epidemiology have influenced guidelines on routine testing for men who have sex with men in sexual health clinics</gtr:impact><gtr:outcomeId>5461e902c0fd33.75667484</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.bashh.org/documents/2013%20LGV%20guideline.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>European Chlamydia guidelines</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:guidelineTitle>2010 European guideline for the management of Chlamydia trachomatis infections</gtr:guidelineTitle><gtr:id>FC293D6B-5593-429B-8EDE-F2BDBD2F9CFF</gtr:id><gtr:impact>The description of LGV in the UK, and the audit of the prevalence of rectal chlamydia in men who have sex with men (both of which were led by LGV-net research team members in collaboration with this project) are cited in relation to the need for new guidelines (2008) and then the new guideline (2010)</gtr:impact><gtr:outcomeId>94B287869BC</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.iusti.org/regions/europe/pdf/2010/Euro_Guideline_Chlamydia_2010.pdf</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed web-based questionnaires to collect detailed information on history, behaviour and symptoms from patients. This is then linked to clinician and laboratory information through unique ID.</gtr:description><gtr:id>32C23111-1AF4-443E-B472-A83F977BE483</gtr:id><gtr:impact>Appears to improve disclosure of certain risk behaviours.</gtr:impact><gtr:outcomeId>209E64F9F5E</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Online questionnaires</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3B4C0F99-4829-45B2-A007-1CB21533FDB6</gtr:id><gtr:title>Risk factors for rectal lymphogranuloma venereum in gay men: results of a multicentre case-control study in the U.K.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03f95033fe49a1b1e3ac594a683e140a"><gtr:id>03f95033fe49a1b1e3ac594a683e140a</gtr:id><gtr:otherNames>Macdonald N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>doi_55f98498427ea42d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15070253-837D-41BB-AAF8-578FBF87DEE9</gtr:id><gtr:title>Clinical predictors of rectal lymphogranuloma venereum infection: results from a multicentre case-control study in the U.K.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad1842aca7f0b40e2f192d7a2bbe7c65"><gtr:id>ad1842aca7f0b40e2f192d7a2bbe7c65</gtr:id><gtr:otherNames>Pallawela SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>pm_540e150e150365667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1FF3353-86C6-444A-A362-32C38A50F989</gtr:id><gtr:title>Challenges Presented by Re-Emerging Sexually Transmitted Infections in HIV Positive Men who have Sex with Men: An Observational Study of Lymphogranuloma Venereum in the UK.</gtr:title><gtr:parentPublicationTitle>Journal of AIDS &amp; clinical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/adbe3ffb2cbf3812dbc1bbe1e09b62f0"><gtr:id>adbe3ffb2cbf3812dbc1bbe1e09b62f0</gtr:id><gtr:otherNames>R?nn M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>589ddf0a025209.79214460</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A060803-2172-4BDF-8A9E-13E284C4479F</gtr:id><gtr:title>Clinical presentation of Lymphogranuloma venereum in a multi-centre case-control study in the UK: LGV-net</gtr:title><gtr:parentPublicationTitle>Hiv Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a90c4c5645129f9f98a8973b9b5985c3"><gtr:id>a90c4c5645129f9f98a8973b9b5985c3</gtr:id><gtr:otherNames>Pallawela S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1464-2662</gtr:issn><gtr:outcomeId>56e057a5373ff8.05969204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2312E837-23AC-45C0-800D-5C9762FCD520</gtr:id><gtr:title>Lymphogranuloma venereum: here to stay?</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f45e5776e73042c1e66fce79d6b5339"><gtr:id>4f45e5776e73042c1e66fce79d6b5339</gtr:id><gtr:otherNames>Ward H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>Bwp54fGrzif</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CEDF198-A1EC-4A79-833A-D95617021719</gtr:id><gtr:title>Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b7dbbbaf5e1c40e86a44aaab0422a9d"><gtr:id>3b7dbbbaf5e1c40e86a44aaab0422a9d</gtr:id><gtr:otherNames>Redmond SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e057a1dd41b4.12937408</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A9C2106-19B3-4468-A38A-EB5290F3425F</gtr:id><gtr:title>The association between lymphogranuloma venereum and HIV among men who have sex with men: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0ba3defdd0d743d98d0ff7857b3d992"><gtr:id>f0ba3defdd0d743d98d0ff7857b3d992</gtr:id><gtr:otherNames>R?nn MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>8DF760AD_48DF760AD_4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B9DFA7D-29EC-452E-9108-23C41E36592E</gtr:id><gtr:title>Clinical presentation of Lymphogranuloma venereum in a multi-centre case-control study in the UK: LGV-net</gtr:title><gtr:parentPublicationTitle>HIV MEDICINE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc348b8f444a7a6b997de5a85146c80c"><gtr:id>dc348b8f444a7a6b997de5a85146c80c</gtr:id><gtr:otherNames>Pallawela S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1464-2662</gtr:issn><gtr:outcomeId>56e057a51a0c77.64038236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00DCEA29-D681-407E-8667-3738D9912776</gtr:id><gtr:title>Characteristics of LGV repeaters: analysis of LGV surveillance data.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/adbe3ffb2cbf3812dbc1bbe1e09b62f0"><gtr:id>adbe3ffb2cbf3812dbc1bbe1e09b62f0</gtr:id><gtr:otherNames>R?nn M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>56e057a4091e25.71274681</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D2CC396-4A87-4A22-8532-0903FAAB214F</gtr:id><gtr:title>Diagnosing chlamydia and managing proctitis in men who have sex with men: current UK practice.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d120e5430eded68abf61f6249e58f36"><gtr:id>0d120e5430eded68abf61f6249e58f36</gtr:id><gtr:otherNames>McMillan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>E6412EB082F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E199B892-1096-4FCF-A35F-95BAEA61886D</gtr:id><gtr:title>Rectal chlamydia--a reservoir of undiagnosed infection in men who have sex with men.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbbe390325b8b934630e5ad7ea046170"><gtr:id>cbbe390325b8b934630e5ad7ea046170</gtr:id><gtr:otherNames>Annan NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>8B29AB3883B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E465841-3C2C-45FB-BE10-967FBE899368</gtr:id><gtr:title>O1-S07.06 Lymphogranuloma venereum in the UK: is there evidence for rectal to rectal transmission? Results of a multicenter case control study</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f45e5776e73042c1e66fce79d6b5339"><gtr:id>4f45e5776e73042c1e66fce79d6b5339</gtr:id><gtr:otherNames>Ward H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>j56cMqcgPYv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30BA1F18-00F1-4530-9597-A94CC7BAA4A3</gtr:id><gtr:title>Risk of pelvic inflammatory disease after Chlamydia infection in a prospective cohort of sex workers.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39805b81c63c9d4885e43efb917b3d25"><gtr:id>39805b81c63c9d4885e43efb917b3d25</gtr:id><gtr:otherNames>Davies B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>doi_16569_31827b9d75</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFD74B92-0ED2-4746-8D78-3C0D0E8BC36D</gtr:id><gtr:title>Asymptomatic Lymphogranuloma Venereum in Men who Have Sex with Men, United Kingdom.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34b6b2c1c6bc81f97b82d5fbf0ec3b08"><gtr:id>34b6b2c1c6bc81f97b82d5fbf0ec3b08</gtr:id><gtr:otherNames>Saxon C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>589dde5f8cbfa3.07790757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3F6CB4F-B8F4-4A49-A00F-8E89BFDD9A31</gtr:id><gtr:title>O1-S10.03 Lymphogranuloma venereum, HIV and high-risk behaviour: findings from LGV enhanced surveillance and mathematical modelling</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5528f5fd9e75b716feabdb4a7a965680"><gtr:id>5528f5fd9e75b716feabdb4a7a965680</gtr:id><gtr:otherNames>Ronn M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>UcFBperQytW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C3D7E2B-1C49-4E4B-9F69-CFBB4B6B17DF</gtr:id><gtr:title>The prevalence of lymphogranuloma venereum infection in men who have sex with men: results of a multicentre case finding study.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f45e5776e73042c1e66fce79d6b5339"><gtr:id>4f45e5776e73042c1e66fce79d6b5339</gtr:id><gtr:otherNames>Ward H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>5D65EF166A4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80B3F105-1724-4762-857B-9A52E1E66AB0</gtr:id><gtr:title>Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey.</gtr:title><gtr:parentPublicationTitle>European journal of public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e99759ccc60cdf4a004708e4136af3d3"><gtr:id>e99759ccc60cdf4a004708e4136af3d3</gtr:id><gtr:otherNames>van den Broek IV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1101-1262</gtr:issn><gtr:outcomeId>5a6f06dad20955.43921225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7F0BCF6-B24B-4E13-8D99-945ADC78F295</gtr:id><gtr:title>Contribution of sexually transmitted infections to the sexual transmission of HIV.</gtr:title><gtr:parentPublicationTitle>Current opinion in HIV and AIDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f45e5776e73042c1e66fce79d6b5339"><gtr:id>4f45e5776e73042c1e66fce79d6b5339</gtr:id><gtr:otherNames>Ward H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1746-630X</gtr:issn><gtr:outcomeId>otsa9owmxgn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA53E39C-CE7D-456A-A501-02F5048D03A4</gtr:id><gtr:title>Lymphogranuloma venereum in men who have sex in men: are we missing a reservoir of infection?</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f45e5776e73042c1e66fce79d6b5339"><gtr:id>4f45e5776e73042c1e66fce79d6b5339</gtr:id><gtr:otherNames>Ward H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>doi_16569_0000000017</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE220478-1661-4A1B-9F75-C824276B3BF6</gtr:id><gtr:title>Translational epidemiology: developing and applying theoretical frameworks to improve the control of HIV and other sexually transmitted infections.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f45e5776e73042c1e66fce79d6b5339"><gtr:id>4f45e5776e73042c1e66fce79d6b5339</gtr:id><gtr:otherNames>Ward H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5461de0c868255.29659642</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E213BBD4-8F91-4324-9672-123AB0D32F11</gtr:id><gtr:title>Lymphogranuloma venereum diagnoses among men who have sex with men in the U.K.: interpreting a cross-sectional study using an epidemic phase-specific framework.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35b4efc69109bd791927470af6316f81"><gtr:id>35b4efc69109bd791927470af6316f81</gtr:id><gtr:otherNames>Hughes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>doi_16569_013_051051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07B0A6C5-67DB-46D3-8A3F-3DC27A2987BD</gtr:id><gtr:title>Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic reviews and mathematical modelling.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/033bdaf4c6cee76248b48b169f74c528"><gtr:id>033bdaf4c6cee76248b48b169f74c528</gtr:id><gtr:otherNames>Althaus CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>pm_540e150e1502b36b5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0683B6CA-D709-4DF0-9AC7-0FD55EC593FC</gtr:id><gtr:title>Developing a conceptual framework of seroadaptive behaviors in HIV-diagnosed men who have sex with men.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/adbe3ffb2cbf3812dbc1bbe1e09b62f0"><gtr:id>adbe3ffb2cbf3812dbc1bbe1e09b62f0</gtr:id><gtr:otherNames>R?nn M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>5461de0b5ce237.25551542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>238FC083-476D-48AD-BCE3-D2115E7EDD1B</gtr:id><gtr:title>Variations in the epidemiology of primary, secondary and early latent syphilis, England and Wales: 1999 to 2008.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/158e6118201fa149950e350c383d9bdf"><gtr:id>158e6118201fa149950e350c383d9bdf</gtr:id><gtr:otherNames>Jebbari H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>pm_16569_29_21262786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3802792C-4C6A-4EFE-A925-6352A01C1B0F</gtr:id><gtr:title>S15.4 Re-emergence of lymphogranuloma venereum in Europe and the public health response</gtr:title><gtr:parentPublicationTitle>Sexually Transmitted Infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f45e5776e73042c1e66fce79d6b5339"><gtr:id>4f45e5776e73042c1e66fce79d6b5339</gtr:id><gtr:otherNames>Ward H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>KKVSVGh2XA7</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601699</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>